Synthesis and biological activity of some 3-(4-(substituted)-piperazin-1-yl)cinnolines. 2011

Eman D Awad, and Mustafa M El-Abadelah, and Suzan Matar, and Malek A Zihlif, and Randa G Naffa, and Ehab Q Al-Momani, and Mohammad S Mubarak
Department of Chemistry, Faculty of Science, University of Jordan, Amman 11942, Jordan.

A new series of 6-substituted-4-methyl-3-(4-arylpiperazin-1-yl)cinnolines 8-10 were synthesized as potential antifungal agents via intramolecular cyclization of the respective 1-(2-arylhydrazono)-1-(4-arylpiperazin-1-yl)propan-2-ones 5-7, mediated by polyphosphoric acid (PPA). The amidrazones themselves were synthesized via direct interaction of the appropriate hydrazonoyl chlorides 4a-d with the corresponding N-substituted piperazine in the presence of triethylamine. The structures of the new prepared compounds were confirmed by elemental analyses, (1)H-NMR, (13)C-NMR, and ESI-HRMS spectral data. The antitumor, antibacterial, and antifungal activity of the newly synthesized compounds was evaluated.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D006574 Heterocyclic Compounds, 2-Ring A class of heterocyclic compounds that include a two-ring fused structure. Both aromatic and non-aromatic ring structures are included in this category. Fused Heterocyclic Compounds, Two-Ring,Two Ring Heterocyclic Compounds,2-Ring Heterocyclic Compounds,Fused Heterocyclic Compounds, Two Ring,Heterocyclic Compounds, 2 Ring
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D020014 K562 Cells An ERYTHROLEUKEMIA cell line derived from a CHRONIC MYELOID LEUKEMIA patient in BLAST CRISIS. Cells, K562

Related Publications

Eman D Awad, and Mustafa M El-Abadelah, and Suzan Matar, and Malek A Zihlif, and Randa G Naffa, and Ehab Q Al-Momani, and Mohammad S Mubarak
January 1979, Annales pharmaceutiques francaises,
Eman D Awad, and Mustafa M El-Abadelah, and Suzan Matar, and Malek A Zihlif, and Randa G Naffa, and Ehab Q Al-Momani, and Mohammad S Mubarak
March 2005, Archiv der Pharmazie,
Eman D Awad, and Mustafa M El-Abadelah, and Suzan Matar, and Malek A Zihlif, and Randa G Naffa, and Ehab Q Al-Momani, and Mohammad S Mubarak
February 2017, Molecular diversity,
Eman D Awad, and Mustafa M El-Abadelah, and Suzan Matar, and Malek A Zihlif, and Randa G Naffa, and Ehab Q Al-Momani, and Mohammad S Mubarak
September 1968, Journal of medicinal chemistry,
Eman D Awad, and Mustafa M El-Abadelah, and Suzan Matar, and Malek A Zihlif, and Randa G Naffa, and Ehab Q Al-Momani, and Mohammad S Mubarak
April 2007, Bioorganic & medicinal chemistry,
Eman D Awad, and Mustafa M El-Abadelah, and Suzan Matar, and Malek A Zihlif, and Randa G Naffa, and Ehab Q Al-Momani, and Mohammad S Mubarak
November 1985, Journal of medicinal chemistry,
Eman D Awad, and Mustafa M El-Abadelah, and Suzan Matar, and Malek A Zihlif, and Randa G Naffa, and Ehab Q Al-Momani, and Mohammad S Mubarak
November 1993, Die Pharmazie,
Eman D Awad, and Mustafa M El-Abadelah, and Suzan Matar, and Malek A Zihlif, and Randa G Naffa, and Ehab Q Al-Momani, and Mohammad S Mubarak
August 2009, Bioorganic & medicinal chemistry,
Eman D Awad, and Mustafa M El-Abadelah, and Suzan Matar, and Malek A Zihlif, and Randa G Naffa, and Ehab Q Al-Momani, and Mohammad S Mubarak
March 2014, European journal of medicinal chemistry,
Eman D Awad, and Mustafa M El-Abadelah, and Suzan Matar, and Malek A Zihlif, and Randa G Naffa, and Ehab Q Al-Momani, and Mohammad S Mubarak
November 1984, Die Pharmazie,
Copied contents to your clipboard!